Evidence map›Paper›PMID 41790296›Full record

ArticleMolecular biology reports2026

HepG2 cells stimulated by THP-1-conditioned medium: a potential in vitro model of systemic inflammation-induced hepatic alterations.

Veronika Vyletelová, Marek Bohunčák, Jana Hricovíniová, Gabriela Greifová, Peter Vavrinec, Jakub Krivý, Dimitris Kardassis, Ľudmila Pašková

Abstract read
In one paragraph

Article in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Veronika VyletelováDepartment of Cell and Molecular Biology of Drugs, Faculty of Pharmacy, Comenius University, Bratislava, 83232, Slovakia.ORCID http://orcid.org/0009-0000-5229-6550
Marek BohunčákDepartment of Cell and Molecular Biology of Drugs, Faculty of Pharmacy, Comenius University, Bratislava, 83232, Slovakia.
Jana HricovíniováDepartment of Cell and Molecular Biology of Drugs, Faculty of Pharmacy, Comenius University, Bratislava, 83232, Slovakia.ORCID http://orcid.org/0000-0001-5098-4122
Gabriela GreifováDepartment of Cell and Molecular Biology of Drugs, Faculty of Pharmacy, Comenius University, Bratislava, 83232, Slovakia.
Peter VavrinecDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, Comenius University, Bratislava, 83232, Slovakia.ORCID http://orcid.org/0000-0003-4612-0879
Jakub KrivýDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, Comenius University, Bratislava, 83232, Slovakia.
Dimitris KardassisDepartment of Basic Sciences, University of Crete Medical School and Institute of Molecular Biology and Biotechnology, F.O.R.T.H, Heraklion, GR-711 10, Greece.ORCID http://orcid.org/0000-0002-8741-1931
Ľudmila PaškováDepartment of Cell and Molecular Biology of Drugs, Faculty of Pharmacy, Comenius University, Bratislava, 83232, Slovakia. paskova@fpharm.uniba.sk.ORCID http://orcid.org/0000-0001-8732-7054

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChronic inflammatory diseases are associated with qualitative and quantitative changes in lipid and lipoprotein metabolism, including high density lipoproteins (HDLs), increasing patients´ susceptibility to atherosclerosis and cardiovascular mortality. Given the liver's central role in lipoprotein metabolism and systemic inflammation, we aimed to develop and investigate an in vitro model of inflammation-induced hepatic metabolic changes. METHODS AND

resultsTo better approximate in vivo conditions, where systemic inflammation exposes the liver to a complex environment rich in cytokines and inflammatory mediators, we exposed human hepatocarcinoma HepG2 cells to conditioned media (CM) from THP-1-derived macrophages using phorbol-12-myristate-13-acetate (PMA) and lipopolysaccharide (LPS). The effect of CM on mRNA expression in HepG2 was tested by quantitative real-time PCR or protein expression by Western blot analysis. Even short-term exposure to CM (2-4 h) led to a significant change in the mRNA expression of inflammatory genes and several transcription factors (e.g., TNF-α, NF-κB, PPARα, and LRH-1). This change was accompanied by alternations in the expression of lipoprotein-associated genes at different time points (e.g. SAA, LDLr, ApoA1, ABCA1, PON1, and PCSK9). After 24 h of exposure, no effect on HepG2 viability was observed.

conclusionIn our model, we observed several significant inflammation-induced changes in hepatic lipoprotein metabolism, making it a valuable in vitro system for further mechanistic studies.

Indexed as

InflammationLiverCulture Media, ConditionedHep G2 CellsHumansLipid MetabolismLipopolysaccharidesMacrophagesNF-kappa BRNA, MessengerTetradecanoylphorbol AcetateTHP-1 CellsTumor Necrosis Factor-alphaCulture Media, ConditionedLipopolysaccharidesNF-kappa BRNA, MessengerTetradecanoylphorbol AcetateTumor Necrosis Factor-alphaAtherosclerosisHepG2InflammationLipid metabolismpiHDLTHP-1

Identifiers

PMID41790296
PMCPMC12966263

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.